Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zigfol-Plus is a combination nutritional supplement marketed by Juvenor Pharma, primarily used in the management of vitamin deficiencies, anemia, and neurological health. It typically contains a combination of **Methylcobalamin** (a form of Vitamin B12), **Folic Acid** (Vitamin B9), and **Pyridoxine Hydrochloride** (Vitamin B6). These components serve as essential cofactors in various metabolic processes, including DNA synthesis, the maturation of red blood cells, and the maintenance of the myelin sheath in the nervous system. Zigfol-Plus is commonly prescribed for conditions such as peripheral neuropathy, megaloblastic anemia, and as a prenatal supplement to prevent neural tube defects during pregnancy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zigfol-Plus.